Literature DB >> 9663895

Effects of acidity, glucose degradation products, and dialysis fluid buffer choice on peritoneal solute and fluid transport in rats.

B Musi1, O Carlsson, A Rippe, A Wieslander, B Rippe.   

Abstract

OBJECTIVE: To evaluate the effects of acidity, glucose degradation products (GDP), and different solution buffer systems on solute and fluid transport during acute peritoneal dialysis (PD) in rats.
DESIGN: Dialysis fluid (16 mL) containing 2.5% glucose as the osmotic agent was instilled intraperitoneally in Wistar rats (280 g) via a thin catheter in dwells lasting 4 hours. Blood and dialysis fluid samples (25 microL) were taken for measurement of glucose, sodium, and radioactive markers. The mass transfer area coefficient (MTAC or PS) for glucose and for 51Cr-EDTA (given as an intravenous infusion) and the peritoneal clearance (Cl) of 125I albumin (RISA), as well as the clearance of RISA to plasma (Cl --> P) were assessed for a commercial, heat-sterilized, acidic PD solution (2.5% glucose, pH 5.5; Gambrosol, Gambro, Lund, Sweden), containing GDP, and for four filter-sterilized solutions containing either lactate (40 mmol/L, pH 5.5 or 7.2), bicarbonate (38 mmol/L, pH 7.2), or pyruvate (40 mmol/L, pH 7.2) as buffers and being devoid of GDP.
RESULTS: The initial pH of the acidic solutions increased rapidly, and attained physiological levels within 40 minutes. The initial drop of sodium, which is expected during the first part of the dwell, was significantly more pronounced with neutral than with acidic lactate. The PS for glucose and 51Cr-EDTA were slightly, but significantly, higher with the acidic and heat-sterilized solution (Gambrosol) than with the neutral, sterile-filtered lactate-buffered solution (p < 0.01), especially early during the dwell. Such an increase may be due to initial vasodilatation, and hence, recruitment of capillaries by the combination of acidity and GDP. However, there were no significant differences with respect to small solute PS values among sterile-filtered solutions, regardless of the presence of acidity or of buffer choice.
CONCLUSION: There were no major differences in fluid and solute transport among sterile-filtered PD solutions having differing buffer systems and pH. Neither were there any effects of GDP alone. However, the combination of a low pH and the presence of GDP in the PD solutions seemed to cause significant increases in peritoneal small solute transport.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9663895

Source DB:  PubMed          Journal:  Perit Dial Int        ISSN: 0896-8608            Impact factor:   1.756


  5 in total

Review 1.  Glucose degradation products (GDP's) and peritoneal changes in patients on chronic peritoneal dialysis: will new dialysis solutions prevent these changes?

Authors:  Murali Krishnan; Paul Tam; George Wu; Andrzej Breborowicz; Dimitrios G Oreopoulos
Journal:  Int Urol Nephrol       Date:  2005       Impact factor: 2.370

2.  Chronic infusion of sterile peritoneal dialysis solution abrogates enhanced peritoneal gene expression responses to chronic peritoneal catheter presence.

Authors:  El Rasheid Zakaria; Paul J Matheson; Ryan T Hurt; Richard N Garrison
Journal:  Adv Perit Dial       Date:  2008

3.  Impact of 3,4-dideoxyglucosone-3-ene (3,4-DGE) on cytotoxicity of acidic heat-sterilized peritoneal dialysis fluid.

Authors:  Tadashi Tomo; Eiji Okabe; Takashi Yamamoto; Shinji Namoto; Tomohiko Iwashita; Kazuhiro Matsuyama; Jun-ichi Kadota
Journal:  J Artif Organs       Date:  2007-03-23       Impact factor: 1.731

4.  Paricalcitol reduces peritoneal fibrosis in mice through the activation of regulatory T cells and reduction in IL-17 production.

Authors:  Guadalupe T González-Mateo; Vanessa Fernández-Míllara; Teresa Bellón; Georgios Liappas; Marta Ruiz-Ortega; Manuel López-Cabrera; Rafael Selgas; Luiz S Aroeira
Journal:  PLoS One       Date:  2014-10-03       Impact factor: 3.240

5.  Conventional versus biocompatible peritoneal dialysis fluids: more questions than answers?

Authors:  Karima Farhat; Frans Jan van Ittersum; Piet Marten Ter Wee; Caroline Ellen Douma
Journal:  NDT Plus       Date:  2008-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.